On Saturday, March, 21, 2020 the U.S. Food and Drug Administration (FDA) gave emergency authorization to Cepheid, a California company, to sell a new test for rapid detection of the pandemic coronavirus SARS-CoV-2, which causes COVID-19. Cepheid’s Xpert® Xpress SARS-CoV-2 test gives healthcare workers results in just 45 minutes, with less than a minute of hands-on time for sample preparation.
As you navigate through our site, certain cookies may be stored in or retrieved from your browser. This information may relate to you, your preferences or your device and is primarily used to ensure that the site functions correctly. The information does not identify you directly, but may help you benefit from an enhanced Web experience. Because we respect your privacy, we give you the opportunity not to allow these cookies.
As you navigate through our site, certain cookies may be stored in or retrieved from your browser. This information may relate to you, your preferences or your device and is primarily used to ensure that the site functions correctly. The information does not identify you directly, but may help you benefit from an enhanced Web experience. Because we respect your privacy, we give you the opportunity not to allow these cookies.
